We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

LGC Clinical Diagnostics

LGC Clinical Diagnostics is a leading provider of Quality Measurement Tools, biological materials, and reagents for t... read more Featured Products: More products

Download Mobile App





LGC Clinical Diagnostics Demonstrates Lab Solutions and Processes to Enhance QC Efficiencies

By LabMedica International staff writers
Posted on 25 May 2023

LGC Clinical Diagnostics (Middlesex, UK) is participating in the 2023 WordLab-EuroMedLab Congress where the company’s quality control experts are demonstrating how automated processes with Multichem independent QC and IAMQC QC data management software can enhance QC efficiencies in the laboratory. More...

LGC’s brands include three IVD manufacturers of QMTs (Maine Standards Company, SeraCare and Technopath Clinical Diagnostics) and one manufacturer of viral and bacterial antigens and antibodies (The Native Antigen Company). At EuroMedLab 2023, LGC is showcasing various product offerings, including Multichem Independent Quality Control, VALIDATE calibration and verification materials, as well as its leading serology portfolio – ACCURUN, alongside its Clinical Genomics portfolio including Seraseq for NGS.

Technopath’s Multichem Independent Quality Control materials have a broader analyte range, enabling extensive consolidation of the test menu. This results in simplified lab inventory, cost reduction, and increased efficiencies. Its flagship products, Multichem IA Plus and Multichem S Plus, combine to offer over 190 tests. These can replace up to 8 rival products, streamlining lab operations. IAMQC Software, designed to support the Multichem QC product line, offers a suite of QC software tools for lab managers and technologists, allowing real-time QC results analysis. It helps automate, centralize, standardize, and enhance QC processes in labs. Its modules can be customized to cater to the different QC needs of individual labs.

The VALIDATE range of calibration and verification materials from Maine Standards Company are user-friendly kits that help document linearity, calibration verification, and linear range verification, as needed by several inspection bodies. They also aid in troubleshooting instrument systems, reagent issues, and calibration inconsistencies. They are available in a variety of product configurations, specifically formulated to maximize reportable ranges with minimum dilutions.

SeraCare's ACCURUN controls and reference materials are developed to be weakly reactive, providing additional confidence in lab test results. SeraCare’s Seraseq Next-generation sequencing (NGS) reference materials aid in building, validating, implementing, and standardizing superior clinical genomics assays. Its customizable biological materials help diagnostic assay developers build more robust assays swiftly. SeraCare's readily accessible antibodies and immunoassay reagents can accelerate research and IVD assay development.

Related Links:
LGC


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Immunofluorescence Analyzer
IFA System
New
Portable POCT Blood Gas Analyzer
BD100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: A large, international study led by City of Hope found that the new, investigational liquid biopsy, called PANXEON, was highly sensitive in detecting stage 1 and 2 pancreatic cancer and had a low rate of false positives. The test was also able to identify high-grade dysplasia, a precancerous condition of the pancreas, potentially enabling intervention before cancer develops. (Photo courtesy of City of Hope)

Multi-Biomarker Blood Test Shows Promise for Early Pancreatic Cancer Detection

Pancreatic cancer has the lowest survival rates of any cancer, with only 14% of patients alive five years after diagnosis. The disease is typically discovered after it has spread, and an estimated 90%... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
Image Credit: Adobe Stock

CAP Updates Cancer Protocols to Refine Breast Cancer Biomarker Reporting and GIST Molecular Testing

Standardized biomarker reporting and molecular profiling are central to pathology-driven cancer care, but evolving practices require laboratories to keep reporting templates current. These templates capture... Read more

Technology

view channel
Image: Graphical Abstract (Wenjie Zhang, Zeyu Luo, Kaijie Liu, et al. Science Bulletin, 2026. doi:10.1016/j.scib.2026.09.016)

Multimodal AI Framework Aims to Guide Cancer Immunotherapy Decisions

Cancer immunotherapy has reshaped oncology, but heterogeneous responses and immune-related toxicities continue to complicate routine decision-making. Standard biomarkers, including programmed death-ligand... Read more

Industry

view channel
Image: The acquisition adds Convergent Genomics’ UroAmp platform and proprietary urinary tumor DNA technology to Veracyte’s portfolio (Photo courtesy of Convergent Genomics)

Veracyte Acquisition Expands Urine-Based Bladder Cancer Monitoring Capabilities

Veracyte, Inc. has acquired Convergent Genomics, expanding its urology diagnostics offerings with the company’s UroAmp platform and proprietary urinary tumor DNA (utDNA) technology. UroAmp has been clinically... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.